Deletion of the metabolic transcriptional coactivator PGC1β induces cardiac arrhythmia

Cardiovascular Research

Volumn 92, Issue 1, 2011, Pages 29-38

  Gurung, Iman S ^a   Medina Gomez, Gema ^a,d   Kis, Adrienn ^a   Baker, Michael ^a   Velagapudi, Vidya ^b   Neogi, Sudeshna Guha ^c   Campbell, Mark ^a   Rodriguez Cuenca, Sergio ^a   Lelliott, Christopher ^a,e   McFarlane, Ian ^c   Oresic, Matej ^b   Grace, Andrew A ^a   Vidal Puig, Antonio ^a   Huang, Christopher L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSIDAD REY JUAN CARLOS   (Spain)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

Cardiac arrhythmia; Lysophosphatidylcholine; Metabolic disease; Mitochondria; Peroxisome proliferator activated receptor coactivator 1

Indexed keywords

CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; ISOPRENALINE; LYSOPHOSPHATIDYLCHOLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; POTASSIUM; POTASSIUM CHANNEL KV1.5; RNA; RYANODINE RECEPTOR 2; SODIUM CHANNEL NAV1.5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ELECTROCARDIOGRAPHY; GENE DELETION; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART MUSCLE CELL; IN VIVO STUDY; MALE; METABOLIC DISORDER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSCILLATORY POTENTIAL; POLYMORPHIC VENTRICULAR TACHYCARDIA; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY CHAIN; RISK FACTOR; RNA TRANSCRIPTION; UPREGULATION;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CARRIER PROTEINS; HOMEOSTASIS; LYSOPHOSPHOLIPIDS; MALE; MICE; MYOCYTES, CARDIAC; POTASSIUM; TRANSCRIPTOME;

EID: 80052902603     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr155     Document Type: Article

References (48)

1. Kahn JK, Sisson JC, Vinik AI. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab 1987;64:751-754. (Pubitemid 17044543)
2. Molon G, Costa A, Bertolini L, Zenari L, Arcaro G, Barbieri E et al. Relationship between abnormal microvolt T-wave alternans and poor glycemic control in type 2 diabetic patients. Pacing Clin Electrophysiol 2007;30:1267-1272. (Pubitemid 47493130)
3. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-2477. (Pubitemid 39552671)
4. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.
5. Pappone C, Santinelli V. Cardiac electrophysiology in diabetes. Minerva Cardioangiol 2010;58:269-276.
6. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307:384-387. (Pubitemid 40139974)
7. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-273. (Pubitemid 36792858)
8. Kelly DP, Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 2004;18:357-368. (Pubitemid 38316342)
9. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor g coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 2006;27: 728-735. (Pubitemid 44936056)
10. Nagai Y, Yonemitsu S, Erion DM, Iwasaki T, Stark R, Weismann D et al. The role of peroxisome proliferator-activated receptor g coactivator-1 b in the pathogenesis of fructose-induced insulin resistance. Cell Metabolism 2009;9:252-264.
11. Ling C, Del Guerra S, Lupi R, Ronn T, Granhall C, Luthman H et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008;51:615-622.
12. Ling C, Poulsen P, Carlsson E, Ridderstrale M, Almgren P, Wojtaszewski J et al. Multiple environmental and genetic factors influence skeletal muscle PGC-1a and PGC-1b gene expression in twins. J Clin Invest 2004;114:1518-1526. (Pubitemid 40385582)
13. Ling C,Wegner L, Andersen G, Almgren P, Hansen T, Pedersen O et al. Impact of the peroxisome proliferator activated receptor-g coactivator-1b (PGC-1b) Ala203Pro polymorphism on in vivo metabolism, PGC-1b expression and fibre type composition in human skeletal muscle. Diabetologia 2007;50:1615-1620. (Pubitemid 47036667)
14. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y et al. The transcriptional coactivator PGC-1b drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab 2007;5:35-46. (Pubitemid 44939399)
15. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003;100:8466-8471. (Pubitemid 36842568)
16. Lin J, Wu PH, Tarr PT, Lindenberg KS, St Pierre J, Zhang CY et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1a null mice. Cell 2004; 119:121-135. (Pubitemid 39349325)
17. Sonoda J, Mehl IR, Chong LW, Nofsinger RR, Evans RM. PGC-1b controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc Natl Acad Sci USA 2007;104:5223-5228. (Pubitemid 47186203)
18. Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP et al. Transcriptional coactivators PGC-1a and PGC-lb control overlapping programs required for perinatal maturation of the heart. Genes Dev 2008;22:1948-1961. (Pubitemid 352008642)
19. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O et al. Transcriptional coactivator PGC-1a controls the energy state and contractile function of cardiac muscle. Cell Metab 2005;1:259-271. (Pubitemid 43960608)
20. Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-g coactivator 1a. Proc Natl Acad Sci USA 2006;103:10086-10091. (Pubitemid 43993627)
21. Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M et al. Ablation of PGC-1b results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 2006;4:e369.
22. Kis A, Murdoch C, Zhang M, Siva A, Rodriguez-Cuenca S, Carobbio S et al. Defective peroxisomal proliferators activated receptor gamma activity due to dominantnegative mutation synergizes with hypertension to accelerate cardiac fibrosis in mice. Eur J Heart Fail 2009;11:533-541.
23. Gray SL, Nora ED, Grosse J, Manieri M, Stoeger T, Medina-Gomez G et al. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferatoractivated receptor g function (P465L PPARg) in mice. Diabetes 2006;55:2669-2677. (Pubitemid 44923664)
24. Laaksonen R, Katajamaa M, Paiva H, Sysi-Aho M, Saarinen L, Junni P et al. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS ONE 2006;1:e97.
25. Katajamaa M, Miettinen J, Oresic M. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 2006;22:634-636. (Pubitemid 43372832)
26. Gurung IS, Kalin A, Grace AA, Huang CL. Activation of purinergic receptors by ATP induces ventricular tachycardia by membrane depolarization and modifications of Ca2+ homeostasis. J Mol Cell Cardiol 2009;47:622-633.
27. Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010;90:207-258.
28. Sobel BE, Corr PB, Robison AK, Goldstein RA, Witkowski FX, Klein MS. Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest 1978;62:546-553. (Pubitemid 9006422)
29. Corr PB, Saffitz JE, Sobel BE. Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart. Basic Res Cardiol 1987;82(Suppl 1):199-208. (Pubitemid 17114095)
30. Schmitz G, Ruebsaamen K. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 2010;208:10-18.
31. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 2008;70: 23-49. (Pubitemid 351738170)
32. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev 1999;79:917-1017. (Pubitemid 29330175)
33. Sato D, Xie LH, Sovari AA, Tran DX, Morita N, Xie F et al. Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias. Proc Natl Acad Sci USA 2009;106:2983-2988.
34. Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev 2005;85:1205-1253. (Pubitemid 41362269)
35. Vianna CR, Huntgeburth M, Coppari R, Choi CS, Lin J, Krauss S et al. Hypomorphic mutation of PGC-1b causes mitochondrial dysfunction and liver insulin resistance. Cell Metab 2006;4:453-464. (Pubitemid 44817352)
36. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003;107:3040-3046. (Pubitemid 36758977)
37. Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev 2008;88: 389-419. (Pubitemid 351520084)
38. Wilensky RL, Shi Y, Mohler ER, Hamamdzic D, Burgert ME, Li J et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 2008;14:1059-1066.
39. Ahumada GG, Bergmann SR, Carlson E, Corr PB, Sobel BE. Augmentation of cyclic AMP content induced by lysophosphatidyl choline in rabbit hearts. Cardiovasc Res 1979;13:377-382. (Pubitemid 9246868)
40. Snyder DW, CraffordWA Jr, Glashow JL, Rankin D, Sobel BE, Corr PB. Lysophosphoglycerides in ischemic myocardium effluents and potentiation of their arrhythmogenic effects. Am J Physiol 1981;241:H700-H707.
41. Liu E, Goldhaber JI,Weiss JN. Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytes. J Clin Invest 1991;88:1819-1832.
42. Burnashev NA, Undrovinas AI, Fleidervish IA, Makielski JC, Rosenshtraukh LV. Modulation of cardiac sodium channel gating by lysophosphatidylcholine. J Mol Cell Cardiol 1991;23(Suppl. 1):23-30.
43. Gautier M, Zhang H, Fearon IM. Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents. J Mol Cell Cardiol 2008;44:241-251. (Pubitemid 351226191)
44. Undrovinas AI, Fleidervish IA, Makielski JC. Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res 1992;71:1231-1241.
45. DaTorre SD, Creer MH, Pogwizd SM, Corr PB. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 1991; 23(Suppl. 1):11-22.
46. Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 1984;55:135-154. (Pubitemid 14032930)
47. Junttila MJ, Barthel P, Myerburg RJ, Mäkikallio TH, Bauer A, Ulm K et al. Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. Heart Rhythm 2010;7:1396-1403.
48. Eisner DA, Venetucci LA, Trafford AW. Life, sudden death, and intracellular calcium. Circ Res 2006;99:223-224. (Pubitemid 44174925)